Sort
8,912 grants matching “sars cov 2”
CRDF Coordinating Center: Logistics Support Under CRDF Global
$850,000Samuel Howerton · National Cancer Institute · Y01 · FY2022 · CA
Developing Durable, Env-Boosted CAR T Cells for HIV Cure
$849,858Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Structure and Dynamics of the SARS-CoV-2 Spike Protein
$848,007Walther H Mothes · Yale University · R01 · FY2021 · AI
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)
$846,715Eugene M. Oltz · Ohio State University · U54 · FY2024 · CA
Development of highly neutralizing nanobodies against HIV-1, SARS-CoV-2 and other pathogens
$846,518Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Characterization of Persistent COVID-19
$846,387Jonathan Li · Brigham And Women'S Hospital · R01 · FY2024 · AI
Development testing of nucleic acid-based vaccine for HIV other indications
$845,848Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
High-Throughput Molecular Profiling Core
$845,786Michael G Katze · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
Characterization of Persistent COVID-19
$845,667Jonathan Li · Brigham And Women'S Hospital · R01 · FY2025 · AI
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
$845,588Constance Ann Benson · University Of California, San Diego · UM1 · FY2020 · AI
Development of a COVID Vaccine Model in NHP
$845,146Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$845,133Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2025 · AI
Dissemination and Implementation of COVID-19 Care Innovations in ED Settings
$845,104Peter James Mendel · Rand Corporation · R01 · FY2022 · AI
Dissecting the drivers of persistent SARS-CoV-2 infections
$844,998Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
Dissecting the drivers of persistent SARS-CoV-2 infections
$844,997Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Novel directions for investigating the role of VGF in comorbid Major Depressive Disorder and Alzheimer's disease
$844,931Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,866Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,801Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,677Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Development of Viral Vaccines against Sarbecoviruses and Merbecoviruses
$844,055Michael S. Diamond · Washington University · P01 · FY2025 · AI
University of Pittsburgh Clinical and Translational Science Institute
$842,907Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2020 · TR
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$842,800Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MH
Core B: Testing and Biorepository
$842,780Eugene M. Oltz · Ohio State University · U54 · FY2020 · CA
DATA MANAGEMENT FOR CANCER DIAGNOSIS PROGRAM ACTIVITIES
$842,461Dave Annette · Information Management Services, Inc. · N02 · FY2023 · CA
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$842,247Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL